TP53 and osteosarcoma: The increased prevalence of osteosarcoma in Li-Fraumeni syndrome [5] and hereditary Retinoblastoma [6], as well as recurrent somatic mutations in TP53 and RB1 [7, 8], strongly implicates these tumor suppressor genes in the pathogenesis of the disease.